Effects of methionine synthase and methionine synthase reductase polymorphisms on hypertension susceptibility
- PMID: 32146711
- DOI: 10.1007/s13258-020-00917-9
Effects of methionine synthase and methionine synthase reductase polymorphisms on hypertension susceptibility
Abstract
Background: Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene are strongly associated with hypertension incidence, although such association is inconsistent among ethnicities studied. However, effects of polymorphisms of other genes related to folate metabolism besides MTHFR on hypertension susceptibility are not well known yet.
Objective: The aim of this study was to elucidate whether methionine synthase (MTR) 2756A>G and methionine synthase reductase (MTRR) 66A>G polymorphisms might be associated with risks of hypertension susceptibility in the Korean population.
Methods: Genotyping of these two polymorphisms was performed for 232 hypertensive patients and 247 unrelated healthy controls using polymerase chain reaction-restriction fragment length polymorphism technique.
Results: In the present study, mutations of MTR 2756A>G and MTRR 66A>G polymorphisms were associated with increased and decreased susceptibility to hypertension, respectively. Allele combinations from these two polymorphisms were also related to hypertension prevalence. When polymorphism data were stratified according to clinical components of hypertension, The G allele of MTR 2756A>G polymorphism was significantly associated with an increased risk of hypertension in subjects with BMI < 26.1 kg/m2 (P = 0.004), WC < 87.2 in. (P = 0.021), FBG < 95.5 mg/dL (P = 0.011), triglyceride < 133.5 mg/dL (P = 0.034), and HDL-cholesterol < 52.2 mg/dL (P = 0.036). The G allele of MTRR 66A>G polymorphism was significantly associated with a decreased risk of hypertension in subjects with WC ≥ 87.2 in. (P = 0.029), FBG ≥ 95.5 mg/dL (P = 0.032) and triglyceride ≥ 133.5 mg/dL (P = 0.027).
Conclusion: MTR 2756A>G and MTRR 66A>G polymorphisms related to folate metabolism might be genetic markers for risk of hypertension in the Korean population.
Keywords: Association; Hypertension; MTR; MTRR; Polymorphism.
Similar articles
-
Associations of MTRR and TSER polymorphisms related to folate metabolism with susceptibility to metabolic syndrome.Genes Genomics. 2019 Aug;41(8):983-991. doi: 10.1007/s13258-019-00840-8. Epub 2019 Jun 18. Genes Genomics. 2019. PMID: 31209768
-
[Folate gene polymorphism and the risk of Down syndrome pregnancies in young Chinese women].Yi Chuan. 2010 May;32(5):461-6. doi: 10.3724/sp.j.1005.2010.00461. Yi Chuan. 2010. PMID: 20466634 Chinese.
-
Analysis of MTR and MTRR Polymorphisms for Neural Tube Defects Risk Association.Medicine (Baltimore). 2015 Sep;94(35):e1367. doi: 10.1097/MD.0000000000001367. Medicine (Baltimore). 2015. PMID: 26334892 Free PMC article.
-
5,10-Methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTRR), and methionine synthase reductase (MTR) gene polymorphisms and adult meningioma risk.J Neurooncol. 2013 Nov;115(2):233-9. doi: 10.1007/s11060-013-1218-z. J Neurooncol. 2013. PMID: 23959833 Clinical Trial.
-
[The role of homocysteine and methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase polymorphisms in the development of cardiovascular diseases and hypertension].Orv Hetil. 2012 Mar 25;153(12):445-53. doi: 10.1556/OH.2012.29326. Orv Hetil. 2012. PMID: 22411217 Review. Hungarian.
Cited by
-
The new mechanism of cognitive decline induced by hypertension: High homocysteine-mediated aberrant DNA methylation.Front Cardiovasc Med. 2022 Oct 24;9:928701. doi: 10.3389/fcvm.2022.928701. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36352848 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical